Lineage Cell Therapeutics
LCTX
LCTX
128 hedge funds and large institutions have $87.9M invested in Lineage Cell Therapeutics in 2025 Q2 according to their latest regulatory filings, with 35 funds opening new positions, 22 increasing their positions, 35 reducing their positions, and 32 closing their positions.
Holders
128
Holders Change
+1
Holders Change %
+0.79%
% of All Funds
1.72%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.04%
New
35
Increased
22
Reduced
35
Closed
32
Calls
$614K
Puts
–
Net Calls
+$614K
Net Calls Change
+$482K
Top Buyers
1 |
1
Millennium Management
New York
|
$2.36M |
2 |
2
Comerica Bank
Dallas,
Texas
|
$4.17M |
3 |
3
Jane Street
New York
|
$1.37M |
4 |
DIG
4
Dauntless Investment Group
Etna,
New Hampshire
|
$731K |
5 |
DC
5
Defender Capital
Charlotte,
North Carolina
|
$6.16M |